Bavarian Nordic — Juni 2020
-
Hej WWW Dejligt at møde dig her. Veloxis er længe siden nu
Det er forskergruppen bag AdaptVac, der nu ser ud til at når et vigtigt skridt på vejen mod en virksom vaccine. Og i givet fald skal Bavarian hjælpe med at producere vaccinen. Jeg tror dog, at det vigtigste næste skridt for Bavarian er at forske i AdaptVac's vaccineteknologi, som i givet fald kan bruges på andre vaccinetyper og sandsynligvis gøre dem væsentligt mere effektive overfor virusinfektioner fremadrettet. Om nogle år! -
Lige over Match.
-
Liverborg: hvis du i KU meddelelsen folder fanen Konsortiet Prevent-nCov og samarbejder ud står der at Bavarian har foreløbig licensaftale. Helt centralt er dog, at det foregår at responset er flere hundrede gange stærkere, end når der vaccineres med antigener uden cVLP’en. Og museblodets evne til at neutralisere virus er ifølge forskerne markant bedre, end hvad der er blevet publiceret fra andre forskeres og virksomheders COVID-19-vaccine.
-
Zealand Pharma skal være med til at udvikle platform for Intomics
Zealand Pharma og Intomics skal sammen udvikle dataplatformen Inbio Discover. Det sker via et researchsamarbejde, oplyser Zealand Pharma onsdag morgen.
Samarbejdet skal gøre det nemmere for det danske selskab at bruge big data, kunstig intelligens og maskinlæring i opdagelsen og udviklingen af den næste generation af peptider som lægemidler.
-
- Vi fortsætter med at forbedre Zealand Pharmas muligheder inden for integrationen af big data med integration og analyse, og denne forskningsaftale vil styrke denne indsats yderligere, siger Rie Schultz Hansen, direktør og chef for Discovery and Innovation hos Zealand Pharma, i en meddelelse om samarbejdet.
Aftalen er toårig.
/ritzau/FINANS
-
CEO Emmanuel Dulac and CFO Matt Dallas will also participate in the 41st Annual Goldman Sachs Global Healthcare Conference held as a virtual event June 9-11, 2020. A company presentation is planned for June 11, 2020 at 10:30 AM Eastern. For more information, please refer to the event website at http://www.goldmansachs.com/gsevents/hcc2020.
-
-
Pga partnerskab Expres2ion / Bavarian Nordic
-
-
Bavarian får Ebolavaccineordre på $13.9 mio fra Janssen http://www.bavarian-nordic.com/investor/news/news.aspx?news=6062
-
Test.
-
Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
Press release – No. 09 / 2020 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific...
GlobeNewswire News Room (www.globenewswire.com)
-
Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go
in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes AssociationZealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
Press release – No. 09 / 2020 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific...
GlobeNewswire News Room (www.globenewswire.com)
-
ZEALAND PHARMA - NY LEDELSE I USA
https://www.proinvestor.com/debat/84684
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind